Cargando…

Development and Validation of a Prediction Model for Cardiovascular Events in Exercise Assessment of Coronary Heart Disease Patients After Percutaneous Coronary Intervention

OBJECTIVE: This study aimed to develop a model for predicting cardiovascular events in the exercise assessment of patients with coronary heart disease after percutaneous coronary intervention (PCI) based on multidimensional clinical information. METHODS: A total of 2,455 post-PCI patients who underw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Tao, Ren, Chuan, Zhao, Wei, Tao, Liyuan, Xu, Shunlin, Zhang, Chengduo, Gao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086511/ https://www.ncbi.nlm.nih.gov/pubmed/35557530 http://dx.doi.org/10.3389/fcvm.2022.798446

Ejemplares similares

Comparison Between Treadmill and Bicycle Ergometer Exercises in Terms of Safety of Cardiopulmonary Exercise Testing in Patients With Coronary Heart Disease
por: Ren, Chuan, et al.
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Cheng, Lele, et al.
Publicado: (2021)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan
por: Akashi, Naoyuki, et al.
Publicado: (2023)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

No Paradoxical Effect of Smoking Status on Recurrent Cardiovascular Events in Patients Following Percutaneous Coronary Intervention: Thai PCI Registry
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy
por: Gao, Mingxin, et al.
Publicado: (2023)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention
por: Li, Jing, et al.
Publicado: (2014)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Differential Evaluating Effect on Exercise Capacity of Cardiopulmonary Exercise Testing and Treadmill Exercise Testing in Post-percutaneous Coronary Intervention Patients
por: Gao, Yifan, et al.
Publicado: (2021)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Temporal Trends in Complex Percutaneous Coronary Interventions
por: Kheifets, Mark, et al.
Publicado: (2022)

Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
por: Zhao, Xiaoxiao, et al.
Publicado: (2020)

A Machine Learning Model to Predict Cardiovascular Events during Exercise Evaluation in Patients with Coronary Heart Disease
por: Shen, Tao, et al.
Publicado: (2022)

Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary intervention therapy: a meta-analysis
por: Chen, Huaigang, et al.
Publicado: (2023)

Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Eyileten, Ceren, et al.
Publicado: (2021)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Editorial: Advances in predicting future adverse coronary events: the role of cardiovascular imaging and coronary physiology indices
por: Seitun, Sara, et al.
Publicado: (2023)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
por: Zhang, Zhipeng, et al.
Publicado: (2023)

Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project
por: Yan, Yan, et al.
Publicado: (2022)

Case report: Constrictive pericarditis after coronary artery perforation during percutaneous coronary intervention
por: Kim, Kyung An, et al.
Publicado: (2023)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study
por: Leonardi, Sergio, et al.
Publicado: (2017)

Validation and Comparison of Six Risk Scores for Infection in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Liu, Yuanhui, et al.
Publicado: (2021)

Comparison of long-term cardiovascular and renal outcomes between percutaneous coronary intervention and coronary artery bypass grafting in multi-vessel disease with chronic kidney disease
por: Kwon, Woochan, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)

Temporal trends in relative survival following percutaneous coronary intervention
por: Hulme, William J, et al.
Publicado: (2019)

Impact of depression on clinical outcomes following percutaneous coronary intervention: a systematic review and meta-analysis
por: Zhang, Wen Yi, et al.
Publicado: (2019)

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
por: Ma, Wen-Rui, et al.
Publicado: (2022)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Association between body mass index and outcomes after percutaneous coronary intervention in multiethnic South East Asian population: a retrospective analysis of the Malaysian National Cardiovascular Disease Database—Percutaneous Coronary Intervention (NCVD-PCI) registry
por: Azhari, Zaid, et al.
Publicado: (2017)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021)

Symptomatic intracerebral hemorrhage after non-emergency percutaneous coronary intervention: Incidence, risk factors, and association with cardiovascular outcomes
por: Lim, Mervyn Jun Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vfp2rn70d6v6idupqgp8nvo8c